Search
for
Sort by
Research 421–450 of 1000+
- Case Report: Repigmentation and complete hair regrowth in an 11-year-old preadolescent with alopecia totalis treated with a JAK inhibitor
- Can homoeopathy cure alopecia areata? a natural healing approach: A case-based study
- Evidence-Based Homeopathy: A case study on alopecia areata in a 6-year-old child
- En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene
- Generalized Pustular Psoriasis
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Skin Diseases in Pregnancy
- A cross-specialty expert opinion on the management of hair loss in gynaecological and endocrinological disorders in Indian patients
- Book Reviews
- Isotretinoin treatment of acne and related disorders: An update
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- TOXIC EPIDERMAL NECROLYSIS
- The Skin in Pregnancy
- Female type of adult acne: Physiological and psychological considerations and management
- Innovative Uses for Zinc in Dermatology
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Microneedling in Dermatology: A Comprehensive Review of Applications, Techniques, and Outcomes
- Female Adolescent Hair Disorders
- Dermatologic Reactions to Targeted Therapy
- Next-Gen Therapeutics for Skin Cancer: Nutraceuticals
- Chemical pharmacotherapy options for managing adult acne
- An overview of zinc and its importance in dermatology-Part II: The association of zinc with some dermatologic disorders
- Herbal Treatment for Dermatologic Disorders
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Rosacea and Rosacea-like Demodicldosis
- NANOEMULGEL AS A RECENT DRUG DELIVERY SYSTEM
- Imipramine-lnduced Alopecia Areata-like Lesions
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma